Search Results - "Barkin, Jack"

Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence by Lawrentschuk, Nathan, Fernandes, Kimberly, Bell, David, Barkin, Jack, Fleshner, Neil

“…Men with castrate resistant prostate cancer have limited treatment options. Although luteinizing hormone-releasing hormone agonists are in the same class, they…”
Get more information

Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis by Nickel, J. Curtis, Barkin, Jack, Forrest, John, Mosbaugh, Phillip G., Hernandez-Graulau, J., Kaufman, David, Lloyd, Keith, Evans, Robert J., Parsons, C. Lowell, Atkinson, Linda E.

“…To compare the current recommended dose of pentosan polysulfate sodium (PPS) with doses two to three times higher. We evaluated three dosages (300, 600, and…”
Get full text

Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial by Nickel, J.Curtis, Downey, Joe, Clark, Janet, Casey, Richard W, Pommerville, Peter J, Barkin, Jack, Steinhoff, Gary, Brock, Gerald, Patrick, Allan B, Flax, Stanley, Goldfarb, Bernard, Palmer, Bruce W, Zadra, Joseph

“…To perform a Canadian multicenter randomized placebo-controlled trial to evaluate the safety and efficacy of 6 weeks of levofloxacin therapy compared with…”
Get full text

Optimizing the management of benign prostatic hyperplasia by Elterman, Dean S., Barkin, Jack, Kaplan, Steven A.

“…One of the challenges facing primary care physicians and specialists as the population ages is the management of lower urinary tract symptoms (LUTS) secondary…”
Get full text

Nocturia: diagnosis and management for the primary care physicians by Barkin, Jack

“…Primary care physicians commonly see men or women with nocturia (or nocturnal polyuria). Nocturia can have a dramatic impact on a patient's physical and…”
Get more information

Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management by Barkin, Jack

“…Significant lower urinary tract symptoms (LUTS) are very common in men over age 50. It is appropriate for the primary care physician to perform the work up to…”
Get more information

Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer by Bass, Roman, Fleshner, Neil, Finelli, Antonio, Barkin, Jack, Zhang, Liying, Klotz, Laurence

“…We assessed the outcomes of high intensity focused ultrasound as primary treatment of localized prostate cancer in a retrospective series. This represents one…”
Get full text

Risks, benefits, and approaches to hormonal blockade in prostate cancer. Highlights from the European Association of Urology Meeting, March 20-24, 2015, Madrid, Spain by Barkin, Jack

“…Several abstracts presented at the 2015 European Association of Urology Meeting highlighted new developments in hormone therapy for prostate cancer management…”
Get more information

POD-06.02: The effects of dutasteride, tamsulosin, and combination therapy on lower urinary tract symptoms and Qmax in men with BPH and prostatic enlargement: Two-year results from the Combination of Avodart® and Tamsulosin (CombAT) study by Roehrborn, C, Paul Siami, P, Jack Barkin, J, Ronaldo Damião, R, Montorsi, F

Get full text

Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California by Barkin, Jack

Get more information

The Changing Role of the Primary Care Physician in the Management of Urologic Conditions by Barkin, Jack

Get more information

Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy by Hassan, Jacob, Barkin, Jack

“…Testosterone deficiency syndrome, which has sometimes been termed age-related or late-onset hypogonadism, is a syndrome characterized by both clinical…”
Get more information

High intensity focused ultrasound (HIFU) by Barkin, Jack

“…Curative treatments for localized prostate cancer, from least invasive to most invasive, include brachytherapy, cryosurgery, three-dimensional conformal…”
Get more information

PSA: The Little Kallikrein that 'COULD' and 'SHOULD' by Barkin, Jack

Get more information

Association between natural killer cell activity and prostate cancer: a pilot study by Barkin, Jack, Rodriguez-Suarez, Roberto, Betito, Katia

“…Natural killer (NK) cells play a significant role in tumor cell immunosurveillance. The association between the activity of NK cells and prostate cancer has…”
Get more information

How I do it: managing bone health in patients with prostate cancer by Barkin, Jack

“…Urologists have two scenarios where they have to address bone loss or increased risk of fractures in men with prostate cancer. In the first setting, a patient…”
Get more information

"How we do it": the new guidebook in urology for primary care physicians by Barkin, Jack

Get more information

The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study by Roehrborn, Claus G, Siami, Paul, Barkin, Jack, Damião, Ronaldo, Major-Walker, Kim, Nandy, Indrani, Morrill, Betsy B, Gagnier, R. Paul, Montorsi, Francesco

“…Abstract Background Combination therapy with dutasteride and tamsulosin provides significantly greater benefit than either monotherapy for various…”
Get full text

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder by Herschorn, Sender, Barkin, Jack, Castro-Diaz, David, Frankel, Jeffrey M, Espuna-Pons, Montserrat, Gousse, Angelo E, Stölzel, Matthias, Martin, Nancy, Gunther, Adrie, Van Kerrebroeck, Philip

“…Objective To assess the efficacy and tolerability of mirabegron 25 mg and 50 mg once-daily vs placebo in patients with overactive bladder (OAB). Materials and…”
Get full text

How I Do It - MRI-ultrasound fusion prostate biopsy using the Fusion MR and Fusion Bx systems by Perlis, Nathan, Lawendy, Bishoy, Barkin, Jack

“…There is increasing evidence to support the use of multiparametric magnetic resonance imaging (MRI) in men at risk for clinically significant prostate cancer…”
Get more information